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Abstract
Background: Interferon induced tetratricopeptide repeat protein 2 (IFIT-2, P54) belongs to the
type I interferon response genes and is highly induced after stimulation with LPS. The biological
function of this protein is so far unclear. Previous studies indicated that IFIT-2 binds to the initiation
factor subunit eIF-3c, affects translation initiation and inhibits protein synthesis. The aim of the
study was to further characterize the function of IFIT-2.
Results: Stimulation of RAW264.7 macrophages with LPS or IFN-γ leads to the expression of IFIT-
2 in a type I interferon dependent manner. By using stably transfected RAW264.7 macrophages
overexpressing IFIT-2 we found that IFIT-2 inhibits selectively LPS induced expression of TNF-α,
IL-6, and MIP-2 but not of IFIT-1 or EGR-1. In IFIT-2 overexpressing cells TNF-α mRNA expression
was lower after LPS stimulation due to reduced mRNA stability. Further experiments suggest that
characteristics of the 3'UTR of transcripts discriminate whether IFIT-2 has a strong impact on
protein expression or not.
Conclusion: Our data suggest that IFIT-2 may affect selectively LPS induced protein expression
probably by regulation at different posttranscriptional levels.
Background
Lipopolysaccharide (LPS) induces a very complex host
response through toll-like receptor (TLR) 4 in macro-
phages. Among these responses, the production of inflam-
matory mediators such as tumor necrosis factor (TNF)
and interleukin (IL)-6 as well as reactive oxygen species
such as nitric oxide (NO) play important roles in protect-
ing the host against bacterial infection. LPS binds to the
TLR4/MD2 complex. Ligand binding leads to the recruit-
ment of adaptor molecules such as MyD88 and Trif.
MyD88 signals through a complex signaling cascade lead-
ing to phosphorylation of the NF-κB inhibitor IκB. IκB is
degraded and NF-κB released in the nucleus where it acts
as a transcription factor for inflammatory response genes.
In addition MyD88 signaling activates MAP kinases such
as p38, JNK and ERK which are also involved in this proin-
flammatory response. Trif-mediated signaling which is
elicited by binding of LPS to TLR-4 or dsRNA to TLR-3
leads to the activation of transcription factors such as IRF-
3 which binds to ISRE elements and induces IFN-β (for
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review see [1-3]. IFN-β in turn induces many interferon
inducible genes such as interferon-induced tetratricopep-
tide repeat proteins (IFIT)-1, IFIT-2 but also amplifies the
expression of MyD88 dependent genes such as IL-12 p70,
IL-6 or TNF-α (for review see [1-3].
Type I interferons have pleiotropic functions [4] including
defense against viruses [5,6] and tumor development
[4,7]. and they also play a role in immunopathological
disorders such as systemic lupus erythematodes (SLE) [8],
sepsis [9] or contribute to pathogenesis of bacterial infec-
tions [10]. Meanwhile many type I interferon induced
genes have been described [11-13], but it is only partially
understood how they contribute to effector functions of
type I interferons.
IFIT-1 (ISG56, P56) and IFIT-2 (ISG54, P54) are induced
in response to type I and type II interferons, dsRNA, LPS,
viral [14] and bacterial infections [15] and they are also
found in several chronic diseases such as inflammatory
bowel disease (IBD) [16] or SLE. Human IFIT-1 and IFIT-
2 as well as mouse IFIT-1 and IFIT-2 are linked genes and
located either on human chromosome 10 or mouse chro-
mosome 19[17,18]. The encoded IFIT-1 and IFIT-2 pro-
teins are related and contain multiple tetratricopeptide-
repeat (TPR) motifs. It was demonstrated that IFIT-1 and
IFIT-2 inhibit translation initiation by inhibiting the
action of the eIF3 protein complex [19-21]. Human IFIT-
1 binds to eIF3e and blocks the ability of eIF3 to stabilize
the ternary complex of eIF2, GTP and Met-tRNA. Mouse
IFIT-1 and mouse IFIT-2 bind to eIF3c and block the abil-
ity of eIF3 to promote formation of the 48 S pre-initiation
complex containing the 40 S ribosomal subunit, the ter-
nary complex, eIF4F and mRNA [21]. Nevertheless so far
no genes have been described which are actually nega-
tively regulated by IFIT-2. To define genes inhibited by
mouse IFIT-2 we generated a stable cell line which consti-
tutively expresses IFIT-2. Our findings suggest that the
3'UTR of certain transcripts determines the selectivity for
IFIT-2 mediated inhibition of protein expression in
RAW264.7 cells.
Results
IFIT-2 selectively inhibits LPS induced protein expression
To confirm previous findings that LPS and interferons
induce IFIT-2 protein expression RAW264.7 macrophages
were stimulated for different time periods with LPS, IFN-
β, Pam3Cys or IFN-γ (Figure 1A). All used stimuli induced
IFIT-2 expression but showed differences in the time
course of IFIT-2 expression. Thus, while IFN-β induced
IFIT-2 expression already 4 hours after stimulation, strong
IFIT expression was detectable 6 hours after LPS stimula-
tion and 12 hours after IFN-γ or Pam3Cys stimulation.
Immunofluorescence staining of RAW264.7 cells showed
that IFIT-2 was located in the cytoplasm (Figure 1B).
Blocking of the IFN-α/β receptor with specific antibodies
against the mouse IFN-α/β receptor subunit 1 (MAR1
mAb) demonstrated that LPS, Pam3Cys and IFN-γ
induced IFIT-2 expression is dependent on endogenous
production of type I interferons (Figure 1C, D). As a con-
trol, blocking antibody against the human IFN-γR (GIR-
218) was used. This data indicates that IFIT-2 seems to be
induced in a specifically type I interferon dependent man-
ner.
Impact of forced IFIT-2 expression on protein expression
In previous reports it was demonstrated that IFIT-2 inter-
acts with eIF-3c, interferes with translation initiation and
inhibits protein synthesis. So far it was unclear whether
IFIT-2 affects protein synthesis globally or in a selective
manner. To address this question RAW264.7 macro-
phages were stably transfected with an IFIT-2 expression
vector. The resulting cells (RAW-IFIT-2) were viable and
showed no obvious defect in proliferation. Constitutive
IFIT-2 expression was detectable (Figure 2).
To define genes which may be potentially regulated by
IFIT-2, RAW264.7 and RAW-IFIT-2 cells were stimulated
with LPS and TNF-α, IL-6, MIP-2, and VEGF secretion was
determined (Figure 3A–D).
Stimulation of RAW 264.7 macrophages led to a dose-
dependent increase of TNF-α secretion. Forced IFIT-2
expression reduced LPS induced TNF-α secretion by more
than 90% indicating that IFIT-2 overexpression affects LPS
induced TNF-α secretion. TNF-α secretion in RAW 264.7
cells stably transfected with the empty vector pEF4/V5-His
A was comparable to RAW 264.7 macrophages after LPS
stimulation (data not shown).
In similar, IFIT-2 overexpression significantly reduced
MIP-2 secretion (more than 80%), and IL-6 secretion
(more than 95%), as detected by ELISA. In contrast, VEGF
secretion was not affected. By using immunoblots the pro-
tein expression of several other LPS induced proteins such
as IFIT-1 and EGR-1 was determined prior to and after LPS
stimulation at different time points. Since EGR-1 expres-
sion is predominantly found in the nucleus, protein
expression of EGR-1 was determined in nuclear extracts.
IFIT-1 and EGR-1 were similarly expressed at indicated
time points in IFIT-2 and parental RAW macrophages
(Figure 4), which was also confirmed by quantification of
the band intensities of immunoblots. Thus, quantifica-
tion of EGR-1 expression 2 h after LPS stimulation
revealed a ratio of EGR-1 found in RAW264.7 compared
to RAW-IFIT-2 cells of 0.9 ± 0.2 :1 (n = four experiments).
Taken together, our data indicate that forced IFIT-2
expression affects LPS induced protein expression in a
selective manner.BMC Immunology 2008, 9:75 http://www.biomedcentral.com/1471-2172/9/75
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IFIT-2 does not affect substantially LPS induced signal 
transduction
To investigate whether IFIT-2 overexpression also affects
LPS mediated signal transduction RAW 264.7 and RAW-
IFIT-2 cells were stimulated with LPS for different time
periods and immunoblots were performed to determine
phosphorylation of ERK, JNK, p38 and IκB using specific
antibodies. As a control total amounts of ERK, JNK, p38,
IκB as well as actin were determined (Figure 5). Band
intensities of three experiments were quantified, normal-
ized to actin and compared for each time point between
RAW264.7 and RAW-IFIT2 cells. Slight differences were
found for phosphorylated IκB 10, 30 and 60 minutes after
LPS stimulation (ratio RAW264.7 : RAW-IFIT-2; 0.7 ± 0.1,
0.7 ± 0.1 and 0.7 ± 0.3) and for phosphorylated p38 only
10 minutes after stimulation (ratio RAW264.7 : RAW-
IFIT-2; 1.4 ± 0.1). Taken together, IFIT-2 overexpression
did not or did only marginally affect phosphorylation of
the investigated signaling molecules. In addition, the
expression patterns of the total amounts of these proteins
over time after LPS stimulation showed only small varia-
tions (data not shown). These data suggest that IFIT-2
overexpression does not affect substantially LPS mediated
signal transduction.
IFIT-2 decreases LPS induced TNF-α mRNA expression by 
affecting mRNA stability
If IFIT-2 only affected protein expression, LPS induced
TNF-α mRNA expression would be expected to be similar
in RAW and RAW-IFIT-2 cells. To investigate whether
mRNA expression is affected by IFIT-2, RAW264.7 and
RAW-IFIT-2 cells were stimulated and IFIT-1 and TNF-α
mRNA expression was determined by Real-time RT-PCR
(Figure 6A–B). While LPS induced IFIT-1 mRNA expres-
sion was not affected by IFIT-2 overexpression, TNF-α
Protein expression of IFIT-2 in RAW 264 Figure 1
Protein expression of IFIT-2 in RAW 264.7 macrophages. RAW 264.7 cells were stimulated with (A) IFN-β (50 U/ml), 
LPS (1 μg/ml), Pam3Cys (1 μg/ml) or IFN-γ (50 ng/ml), pretreated with GIR-208 or MAR1 prior to (C) LPS, (D) Pam3Cys or 
IFN-γ stimulation for indicated time periods and IFIT-2 and β-actin expression was detected by immunoblots. (B) RAW 264.7 
cells were stimulated with or without IFN-β, staining was performed using anti-IFIT-2 and a secondary Cy2-labeled goat anti-
rabbit antibody (green), Phalloidin-Tritc (red) and DAPI (blue) and detected by immunofluorescence. Big pictures; IFIT-2 
expression, small pictures overlay of phalloidin and DAPI staining. At least three independent experiments with similar results 
with exception of B (two experiments).BMC Immunology 2008, 9:75 http://www.biomedcentral.com/1471-2172/9/75
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mRNA expression levels were decreased significantly up to
two-fold four and six hours after stimulation.
To assess whether mRNA stability was affected by IFIT-2
overexpression, RAW264.7 and RAW-IFIT-2 clones were
stimulated with LPS for 2 hours. Subsequently cells were
treated with actinomycin D and mRNA expression was
determined by Real-time PCR at different time points
(Figure 6C). The stability of TNF-α mRNA was signifi-
cantly decreased in RAW IFIT-2 cells. The half-life of TNF-
α mRNA in LPS stimulated RAW264.7 cells (t1/2 = 25 min-
utes) was approximately two-fold higher than in RAW-
IFIT-2 cells (t1/2 = 13 minutes). This finding explains the
differences in TNF-α mRNA levels found between LPS
stimulated RAW264.7 and RAW-IFIT-2 cells but not the
differences in protein expression levels.
Our data indicate that forced IFIT-2 expression selectively
affects mRNA stability and protein expression of some
genes, e.g. TNF-α. This raised the question by which
mechanism IFIT-2 specifically affects protein expression.
Characteristics of the 3'UTR of transcripts specify IFIT-2 
mediated control of protein expression
Previous studies showed that distinct elements in the
3'UTR such as the GAIT element which was found in the
3'UTR of ceruloplasmin play an important role for trans-
lational control [22-24]. Therefore we hypothesized that
the 3' UTR of transcripts might determine the selectivity of
IFIT-2 to inhibit protein synthesis. To investigate whether
characteristics of different 3'UTRs may be important for
IFIT-2 mediated inhibition of protein expression, RAW
264.7 and RAW-IFIT-2 cells were co-transfected with an
expression vector expressing cherry flanked by a polyA sig-
nal but without 3'UTR (as a control for transfection effi-
ciency) and different expression vectors encoding for
EGFP flanked by no 3'UTR (GFP), the TNF-α, MIP-2, IL-6,
IFIT-1 or VEGF 3'UTR. Subsequently cherry and EGFP
expression was determined by flow cytometry (Figure 7).
To ensure that only transfected cells were investigated,
only cells were analyzed which expressed cherry. The
mean fluorescence for EGFP expression was comparable
in RAW264.7 and RAW-IFIT-2 cells if an EGFP expression
vector was used flanked by no 3'UTR. Transfection exper-
iments using EGFP constructs flanked by the 3'UTR of
TNF-α, IL-6 and MIP-2 revealed that EGFP expression was
approximately 70% reduced in RAW-IFIT-2 compared to
RAW264.7 cells. In contrast the 3'UTRs of IFIT-1 and
VEGF had only a minor effect on EGFP expression. These
data indicate that the 3'UTR plays an important role for
the specificity of IFIT-2 to inhibit protein expression in
RAW macrophages. One of the best studied 3'UTRs is the
TNF-α 3'UTR and regions are defined which are important
for posttranscriptional regulation such as the AU-rich
region (ARE) which controls mRNA decay and translation
and the constitutive decay element (CDE) which also
affects mRNA stability [25-27].
To define a distinct element in the 3'UTR of TNF-α,
RAW264.7 and RAW-IFIT-2 cells were transfected with
constructs encoding EGFP flanked by deletion mutants of
the 3'UTR of TNF-α (Figure 8). EGFP expression was sig-
nificantly reduced by more than 70% in IFIT-2 cells com-
pared to RAW264.7 cells using the constructs TNF 862–
Protein expression of stably transfected RAW-IFIT-2 cells Figure 2
Protein expression of stably transfected RAW-IFIT-2 cells. IFIT-2 expression was detected in RAW 264.7 and RAW-
IFIT-2 cells by (A) immunoblot or (B) intracellular staining and flow cytometry (at least two experiments).BMC Immunology 2008, 9:75 http://www.biomedcentral.com/1471-2172/9/75
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1621 (P1) and TNF 1340–1621 (P3). Since P3 lacks the
proximal part of the 3'UTR including the AU-rich region
one can conclude that the ARE plays no role for the IFIT-
2 mediated inhibition of expression. In contrast, transfec-
tion with TNF 862–1380 (P7) resulted in a similar GFP
expression in both RAW264.7 and RAW-IFIT-2 cells indi-
cating that the distal part of the 3'UTR containing the CDE
element is essential for IFIT-2 mediated inhibition of
expression.
Discussion and conclusion
Previous studies demonstrated that IFIT-2 is highly
expressed after stimulation with LPS as well as interferons.
Our findings confirm these studies and show that LPS as
well as IFN-γ induced IFIT-2 expression is dependent on
endogenous secretion of type I interferons. Therefore one
can assume that IFIT-2 may represent an effector protein
which may be responsible for some of the effects which
are associated with type I interferon function.
Although IFIT-2 has been known for quite a long time and
is strongly expressed in many diseases such as SLE, inflam-
matory bowel diseases, and viral or bacterial infections,
little is known about the biological function of this pro-
tein. Recently it was demonstrated that mIFIT-2 inhibits
translation by binding to eIF-3c, interferes with transla-
tion initiation and inhibits protein synthesis at least in in
vitro translation assays [19,21]. Although these studies
clearly showed that IFIT-2 could be involved in regulation
of protein synthesis it was so far totally unclear whether
Forced IFIT-2 expression modulates protein expression Figure 3
Forced IFIT-2 expression modulates protein expression. RAW264.7 and RAW-IFIT-2 cells were stimulated with 1 μg/
ml or as stated LPS for 24 h or as stated and (A) TNF-α-, (B) IL-6, (C) MIP-2 or (D) VEGF secretion was determined by ELISA. 
Significant differences (two-way ANOVA or t-test) were found for TNF-α, IL-6 and MIP-2 (p < 0.001). Three independent 
experiments with similar results.BMC Immunology 2008, 9:75 http://www.biomedcentral.com/1471-2172/9/75
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IFIT-2 affects protein expression in a global or selective
manner.
The presented study may shed some light on the function
of IFIT-2. As shown here forced IFIT-2 expression does not
globally affect protein expression but acts in a more spe-
cific manner. We could identify several proteins which are
induced by LPS and which are inhibited in protein expres-
sion by forced IFIT-2 expression. Examination of LPS trig-
gered phosphorylation of signal molecules of TLR-4
signaling pathways in cells with or without forced IFIT-2
expression excludes that IFIT-2 substantially affects signal
transduction. This data indicates that the principal mech-
anism of IFIT-2 mediated inhibition of LPS triggered
cytokine secretion is for instance different to the negative
regulation mediated by FLN29 [28]. FLN29 which is
induced eight hours after LPS stimulation in a Trif-
dependent manner interacts with TRAF6 and inhibits IκB
and ERK phosphorylation after restimulation with LPS.
Thus, our data using cells overexpressing IFIT-2 argue
against the possibility that LPS induced IFIT-2 may affect
prominently signal transduction of the tested pathways as
it was demonstrated for FLN29 [28]. As shown for TNF-α
as an example, forced IFIT-2 overexpression in RAW cells
affects to some extent mRNA expression. Actinomycin D
treatment shows that reduced TNF-α mRNA expression is
associated with reduced mRNA stability. This data
strongly argues that IFIT-2 overexpression mediates
reduced mRNA stability and therefore acts posttranscrip-
tionally. Nevertheless, we cannot totally rule out that to
some extent also transcription might be affected. Since
TNF-α mRNA expression is only reduced up to 50%,
reduced mRNA stability does not totally explain reduced
protein expression. Therefore, we conclude that forced
IFIT-2 expression may act at different levels of posttran-
scriptional regulation. At this point we do not know
whether these processes act separately or are linked
together. Since not all proteins and especially not all LPS
induced proteins are affected by forced IFIT-2 expression
we initiated studies to determine possible mechanisms for
the action of IFIT-2.
Several other reports pointed out that specific transla-
tional control is determined by distinct elements in the
3'UTR to which proteins bind and this interaction of RNA
binding proteins with distinct sequence stretches medi-
ates translational silencing. For instance it was described
that IFN-γ stimulation leads to formation of the GAIT pro-
tein complex consisting of four proteins which bind to
distinct stem loops in the 3'UTR of ceruloplasmin [22-
24]. These interactions interfere with translation initia-
tion. Therefore we wanted to investigate whether the char-
acteristics of 3'UTRs of the genes we addressed in this
study discriminate whether IFIT-2 mediates inhibition of
protein expression or not.
By transfection of plasmids expressing EGFP flanked by
different 3'UTRs in RAW264.7 and RAW-IFIT-2 cells we
could demonstrate that IFIT-2 affects EGFP expression
dependent on the 3'UTR attached to the coding sequence
of EGFP. Consistent with decreased TNF-α, MIP-2 and IL-
6 secretion after LPS stimulation in RAW-IFIT-2 cells,
3'UTRs of TNF-α, MIP-2 and IL-6 mediated lower EGFP
expression in RAW-IFIT-2 cells compared to RAW264.7
cells. In contrast, the 3'UTRs of IFIT-1 or VEGF did not
influence EGFP expression in RAW-IFIT-2 cells. We con-
EGR-1 and IFIT-1 expression in RAW-IFIT-2 cells after LPS stimulation Figure 4
EGR-1 and IFIT-1 expression in RAW-IFIT-2 cells after LPS stimulation. Immunoblots were performed after LPS 
stimulation of cells for detection of (A) EGR-1 and Histone H3 in the nucleus or (B) IFIT-1 and actin in whole cell lysates. 
Three independent experiments with similar results.BMC Immunology 2008, 9:75 http://www.biomedcentral.com/1471-2172/9/75
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clude that specific properties of the 3'UTRs determine
whether IFIT-2 affects protein expression of a certain gene
or not. There is already detailed knowledge about differ-
ent elements of the TNF-3'UTR for the posttranscriptional
regulation. Thus, the AU-rich elements (ARE) are impor-
tant for posttranscriptional regulation. When inserted
into reporter constructs, the ARE of TNF-α induces proces-
sive deadenylation of the mRNA and efficiently targets the
body of the transcript for rapid degradation [26,29]. In
addition, the ARE of TNF-α inhibits stable association
with the 40 S ribosomal subunit and prevents translation
[27]. Decay is mediated through binding of the zinc finger
protein tristetraprolin (TTP) to the ARE, as shown with
TTP-deficient mice which show elevated levels of TNF-α
due to an increase in the mRNA half-life [30]. Additional
proteins such as huR and TIA-1 interact with the ARE and
influence mRNA stability and translation [31,32]. In addi-
tion the constitutive decay element (CDE) was described
which constitutively mediates decay of TNF-α mRNA
[25]. However no proteins were so far described which
may bind to the CDE element.
Our experiments using RAW264.7 and RAW-IFIT-2 cells
transfected with EGFP constructs flanked by different
3'UTRs clearly indicate that the characteristics of the
3'UTRs define whether forced IFIT-2 expression can medi-
ate inhibition of protein expression or not. Deletion of
parts of the 3'UTR of TNF-α revealed that the distal part of
the 3'UTR containing the CDE element is sufficient for
IFIT-2 mediated inhibition of protein expression while
the ARE element has no impact. How IFIT-2 controls pro-
tein expression via 3'UTRs remains to be elucidated in fur-
ther studies. Taken together, our data suggest that IFIT-2
acts as a regulatory protein which may repress the protein
expression of distinct genes.
At this point, however, the number of proteins which may
be affected by IFIT-2 is not known. Therefore, it is hard to
predict how this function of IFIT-2 may translate finally
into in vivo function of IFIT-2 as an interferon induced
effector protein. In further studies it is necessary to inves-
tigate the in vivo function of IFIT-2 by additional tools
such as IFIT-2 knock-out mice.
Methods
Reagents and antibodies
Ultra pure LPS from S. enterica serovar Minnesota was pur-
chased from EMD Chemicals (Gibbstown, NJ). Recom-
binant mouse IFN-β and IFN-γ were purchased from R&D
Systems (Minneapolis, MA). Actinomycin D was obtained
from Sigma (St Louis, MO). Anti-mouse β-actin antibody
was purchased from Sigma. Antibodies against phospho-
p44/42, p44/42, IκB-α, phospho-IκB-α were from Cell
Signaling Technology (Danvers, MA). Pan-JNK/SAPK1,
phospho-JNK/SAPK, p38 and phospho-p38 specific anti-
bodies were purchased from BD Biosciences (Franklin
Lakes, NJ). Anti-EGR-1 antibody was from Santa Cruz
(Santa Cruz, CA) and anti-Histone H3 from BioLegend
(San Diego, CA). Horseradish peroxidase labeled rabbit
anti-mouse and swine anti-rabbit antibodies were
obtained from DAKO (Glostrup, Denmark). Monoclonal
antibodies against the mouse IFN-α/β receptor subunit 1
(MAR-1) [33] and the human IFN-γR (GIR-218) [34] were
kindly provided by R.D. Schreiber and Kathleen C.F. Shee-
han, Washington University St. Louis.
Cell culture and cell culture assays
RAW264.7 cells were maintained in Dulbecco's modified
Eagle's medium (Invitrogen, Carlsbad, CA) supplemented
with 10% fetal bovine serum (Sigma), 4 mM L-glutamine
(Invitrogen), 1 mM sodium pyruvate (Biochrom KG, Ber-
lin, Germany), 100 units/ml penicillin (Invitrogen) and
100 μg/ml streptomycin (Invitrogen) in a humidified 5%
CO2 atmosphere at 37°C.
Impact of IFIT-2 on LPS mediated signal transduction Figure 5
Impact of IFIT-2 on LPS mediated signal transduc-
tion. RAW and RAW-IFIT-2 cells were stimulated with LPS 
(1 μg/ml) for indicated time periods. Immunoblots were per-
formed for total and phosphorylated proteins as indicated. 
Three independent experiments with similar results.BMC Immunology 2008, 9:75 http://www.biomedcentral.com/1471-2172/9/75
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Plasmids and preparation of stable transformants
The full-length mIFIT2 was amplified by PCR from cDNA
of IFN-β stimulated RAW cells using the primers 5'-GGA
TCC ATG AGT ACA ACG AGT AAG GAG TCA C3' and 5'-
GCG GCC GCC TAG TAT TCA GCA CCT GCT TCA TCC-
3'. The PCR fragment was cloned into pEF4/V5-His A (Inv-
itrogen, Carlsbad, CA). The plasmid was delivered to
RAW264.7 cells using ExGen transfection reagent (Fer-
mentas, Burlington, Canada). Transfectants were selected
in Zeocin™ containing medium (0.5 mg/ml) (Invitrogen).
pMCherry-C1 was generated by replacing the DsRed2
sequence of the expression vector pDsRed2-C1 (Invitro-
gen) by the sequence of mCherry. mCherry was generated
by PCR using the vector mCherry-pRSET-B [35] as a tem-
plate kindly provided by Roger Y. Tsien, University of San
Diego. To obtain constructs which encode for EGFP and
contain 3'UTRs of TNF-α, fragments of the 3'UTR of TNF-
α, 3'UTR of MIP-2, IL-6, IFIT-1 and VEGF, cDNA from LPS
stimulated RAW264.7 cells was used as template to
amplify PCR products using specific oligonucleotides
TNF-α and IFIT-1 mRNA expression in RAW-IFIT-2 cells Figure 6
TNF-α and IFIT-1 mRNA expression in RAW-IFIT-2 cells. RAW and RAW-IFIT-2 cells were stimulated with LPS (1 μg/
ml) for indicated time periods and mRNA expression was detected for (A) TNF-α and (B) IFIT-1 by Real Time RT-PCR nor-
malized to the house keeping gene RPL8. Data are shown as fold increased expression compared to unstimulated cells. Aster-
isks indicate significant differences p < 0.005 (Two-Way Anova). (C) Cells were stimulated for two hours with LPS and then 
treated for indicated time periods with actinomycin D. TNF-α and RPL8 mRNA expression was determined by Real-time RT 
PCR. Data are shown as percentage of the remaining mRNA after actinomycin on logarithmic scale. T1/2 was determined using 
the means and standard deviations summarizing three independent experiments.BMC Immunology 2008, 9:75 http://www.biomedcentral.com/1471-2172/9/75
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which contained different restriction sites (TNF: P1, 5'-
CTC GAG TGA AGG GAA TGG GTG TTC ATC-3', 5'-GGA
TCC CTT TTC CAA GCG ATC TTT ATT TCT CTC-3'; P3, 5'-
AAG CTT TGA ATG TAT TTA TTT GGA AGG CCG-3', 5'-
GGA TCC CTT TTC CAA GCG ATC TTT ATT TCT CTC-3';
P7 5'-CTC GAG TGA AGG GAA TGG GTG TTC ATC-3', 5'-
GGA TCC GGG TCC TCC AGG ACA CCC C-3'; IFIT1, 5'-
CTC GAG TGA ATG CAG CTC ACC TCT GTG-3', 5'-GGA
TCC GAG GGG AAT ATG TTT ATT TGG AC-3'; IL-6 5'-CTC
GAG TAG TGC GTT ATG CCT AAG CAT ATC AG-3', 5'-TTT
ATT TGT TTG AAG ACA GTC TAA ACA TTA TAA AAA TAC
ATC CA-3'; MIP-2, 5'-CTC GAG TGA CCT GGA AAG GAG
GAG CC-3', 5'-GGA TCC AAC AGA CGT TTT TAT TTT TTG
TTA TTT G-3'; VEGF 5'-CTC GAG TGA GCC AGG CTG
CAG GAA GG-3', 5'-AAG CTT TTT GAG ATC AGA ATT
CAA TTC TTT AAT AC-3'). PCR products were subcloned
into pCR-Blunt II Topo and then cloned into pEGFP-C3.
All constructs were verified by sequencing. Sequencing of
the TNF-α 3'UTR which was also used as template for all
TNF 3'UTR mutants revealed a slight modification at the
3' end in comparison to the reference sequence
NM_013693 resulting at position 1601–1605 in AGTCA
instead of GGGTC.
Preparation of GST fusion proteins and antibody 
production
DNA fragments encoding mIFIT-2 and mIFIT-1 were sub-
cloned into GST fusion protein expression vector pGEX-
4T3 (Amersham Biosciences) and transformed into E. coli
strain BL21. GST fusion proteins were expressed and puri-
fied by affinity chromatography. Anti-IFIT-1 and IFIT-2
antibodies were raised in rabbits by immunizing with a
full-length protein of bacterially expressed recombinant
GST-IFIT-1 and GST-IFIT-2. The generated antibodies
Impact of 3'UTRs on IFIT-2 mediated inhibition of protein expression Figure 7
Impact of 3'UTRs on IFIT-2 mediated inhibition of protein expression. RAW and RAW-IFIT-2 cells were co-trans-
fected with expression vectors encoding GFP with no 3 'UTR (GFP) or GFP with the indicated 3'UTRs (TNF, IL-6, MIP-2, 
VEGF, IFIT-1) and an expression vector encoding cherry with no 3'UTR for four hours. Flow cytometry of cells was performed 
and gated on cherry expressing cells representing efficiently transfected cells. (A) shows the mean of several experiments (n = 
3–8) of the percentage of reduction of the mean GFP fluorescence of RAW-IFIT-2 compared to RAW264.7 cells for each con-
struct used. (B) illustrates the histograms of the GFP fluorescence of one representative experiment. Asterisks indicate signifi-
cant differences (p < 0.05, one-way ANOVA, Dunnett test) compared to control (GFP, no UTR).BMC Immunology 2008, 9:75 http://www.biomedcentral.com/1471-2172/9/75
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were subsequently affinity-purified (Biogenes, Berlin,
Germany).
Western Blotting
2 × 106 RAW cells were seeded overnight in 6-well plates
and then stimulated under different conditions. At differ-
ent time points cells were washed with PBS and lysed for
30 min on ice in lysis buffer (50 mM Tris-HCl pH 7.5, 150
mM NaCl, 0.5% NP40, 400 μM DTT, 1 mM Na3VO4) con-
taining a protease inhibitor cocktail (Roche Diagnostics,
Mannheim, Germany). The insoluble material was
removed by centrifugation at 15000 g for 10 min at 4°C.
Protein concentration was determined using the Bio-Rad
protein assay (Bio-Rad, Hercules, CA) according to the
manufacturer's instructions. 25–50 μg of protein were
separated on sodium dodecyl sulfate (SDS)-polyacryla-
mide gels and blotted onto Immobilon-P PVDF mem-
branes (Millipore, Bedford, MA). The membranes were
blocked with 5% nonfat dry milk in TBST (10 mM Tris-
HCl, 150 mM NaCl, 0.5% Tween 20, pH 7.4) for 1 h at
room temperature. Incubation with primary antibodies
was performed overnight at 4°C followed by incubation
with the appropriate HRP-conjugated secondary antibody
for 1 h at room temperature. Immunoreactive bands were
visualized using the ECL system (GE Healthcare, Köln,
Germany) according to the manufacturer's instructions.
In some cases band intensities of immunoblots were
quantified and normalized to house keeping proteins by
using Quantity One software, Bio-Rad Laboratories (Her-
cules, CA). Ratio of band intensities of RAW264.7 and
RAW-IFIT-2 cell lysates was calculated for each immunob-
lot. Means and standard deviations presented were
obtained from at least three experiments.
To generate nuclear extracts cells were scraped off in PBS
and centrifuged for 5 min at 400 g. Cells were lysed in
Impact of deletions in the TNF-α 3'UTR on IFIT-2 mediated inhibition of protein expression Figure 8
Impact of deletions in the TNF-α 3'UTR on IFIT-2 mediated inhibition of protein expression. RAW and RAW-
IFIT-2 cells were co-transfected with expression vectors encoding GFP with no 3'UTR (GFP) or GFP with the indicated 
3'UTRs and an expression vector encoding cherry with no 3'UTR for four hours. (A) depicts the constructs used, (B) shows 
the mean of several experiments (n = 3–8) of the percentage of reduction of the mean GFP fluorescence of RAW-IFIT-2 com-
pared to RAW264.7 cells for each construct used. Asterisks indicate significant differences (p < 0.05, one-way ANOVA, Dun-
nett test) compared to control (GFP, no UTR). (C) illustrates the histograms of the GFP fluorescence of one representative 
experiment.BMC Immunology 2008, 9:75 http://www.biomedcentral.com/1471-2172/9/75
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hypotonic buffer A (20 mM Hepes pH 7.9, 10 mM KCl,
0.1 mM Na3VO4, 1 mM EDTA, 0.2% NP40, 10% glycerol,
1 mM DTT, complete protease inhibitor cocktail (Roche))
for 5 min on ice. Nuclei were pelleted for 2 min at 15000
g and suspended in hypertonic buffer B (420 mM NaCl,
20% glycerol, 20 mM Hepes pH 7.9, 10 mM KCl, 0.1 mM
Na3VO4, 1 mM EDTA, complete protease inhibitor cock-
tail, 1 mM DTT). After 30 min incubation on ice insoluble
material was removed by centrifugation and nuclear
extracts were stored at -80°C.
Quantitative RT-PCR analysis
Total RNA of RAW264.7 cells seeded in 6-well plates at a
density of 2 × 106 cells per well was extracted using the
RNeasy Mini Kit (Qiagen). 2 μg of RNA were reverse tran-
scribed as described [36]. Semiquantitative Real-time PCR
was performed on a TaqMan 5700 (Applied Biosystems,
Foster City, CA), using Platinum qPCR Super Mix UDG
(Invitrogen) and the Assay-on-Demand primer/probe
mixes Mm00657299_g1 (ribosomal protein L8 (RPL8),
Mm00515153_m1 (IFIT-1) and Mm00443258_m1 (TNF-
α) (Applied Biosystems, Foster City, CA). Results were
quantified using the 2-ΔΔC
T method [37,38]. TNF-α and
IFIT-1 mRNA expression levels were normalized to the
expression of the house keeping gene RPL8.
Measurement of cytokines
3.5 × 105 RAW cells were seeded overnight in 24 well
plates and then stimulated under different conditions. At
different time points supernatants were collected. ELISAs
were performed to measure concentrations of TNF-α and
IL-6 (BD Biosciences), VEGF and MIP-2 (R&D systems)
according to the manufacturer's instructions.
Detection of IFIT-2 expression in cells
For immune fluorescence staining, cells were cultured on
glass slides in 24 well plates. After fixation of the monol-
ayers with 3% paraformaldehyde solution and subse-
quent permeabilization with 2% Triton-X100 in PBS, cells
were stained with rabbit polyclonal anti-mouse IFIT-2
antibody. Subsequently cells were stained with a goat
anti-rabbit Cy2 (Dianova, Hamburg, Germany) and
TRITC-conjugated phalloidin (Sigma) followed by DAPI
(Merck, Darmstadt, Germany). The fluorescence images
were obtained with a confocal laser scanning microscope
(Leica DM IRE2). Intracellular IFIT-2 staining was per-
formed using the Cytofix/Cytoperm kit (BD Biosciences)
according to the manufacturer's instructions. For staining
a polyclonal anti-IFIT-2 and goat-anti-rabbit IgG-PE anti-
body (BD Biosciences) were used.
Determination of EGFP and mCherry expression by flow 
cytometry
The expression vector pmCherry-C1 was delivered into
RAW cells by nucleofection using an Amaxa electropora-
tor (Amaxa, Gaithersburg, MD) according to the manufac-
turer's instructions. Cells were co-transfected with pEGFP-
C3 and pEGFP-C3 variants encoding different 3'UTRs as
illustrated in Figure 7 and 8 and mutants of the 3'UTR of
TNF-α. Four hours after transfection cells were harvested
and analyzed by flow cytometry using a FACSCalibur
(Becton Dickinson, Heidelberg, Germany). To determine
changes in EGFP expression between RAW264.7 and
RAW-IFIT-2 cells only living cells expressing mCherry
were included for histogram analysis of EGFP expression.
Statistics
Statistical analyses were performed using the Graph pad
prism 4.0 software and the appropriate statistical test as
indicated in the figures. For statistical analysis of cytokine
secretion determined by ELISA we used the means and
standard deviations of four samples, representing two bio-
logical replicates and from each biological two technical
replicates. For mRNA expression the means and standard
deviations of two biological replicates were analyzed. All
experiments were repeated in total three times if not oth-
erwise stated.
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